Profusa, Inc.
Profusa, Inc. scores highest on Earnings (100) and lowest on Nitro (1). Its PosiPenta is 60.24 out of 100, better than most similar companies.
On the Penta Grid this week, Profusa, Inc. is Grid #143 of 837 in the Healthcare sector in United States, and Grid #594 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Profusa, Inc. | 60.24 | 50 | 100 | 1 | 95 | 56 |
| GlucoTrack, Inc. | 11.35 | 0 | 1 | 2 | 10 | 44 |
| Curis, Inc. | 42.16 | 96 | 43 | 5 | 41 | 26 |
| Bone Biologics Corporation | 42.16 | 48 | 49 | 14 | 67 | 32 |
| Lakewood-Amedex Biotherapeutics, Inc. | 28.54 | 48 | 10 | 1 | 38 | 46 |
| Artelo Biosciences, Inc. | 28.28 | 48 | 40 | 2 | 39 | 12 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 0.00 |
| P/B ratio | -0.02 |
EEarnings
| Trailing EPS | ₹84983.94 |
| Forward EPS | — |
NNitro
| Price | 88.19 |
| 52-week high | 284144.86 |
| 52-week low | 86.19 |
| Fall from 52-week high | 100.0% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.56 |
AAnchor
| Beta (price swings) | 0.50 |
| Market cap | ₹5 Cr |
| Insider holding | 41.71% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Profusa, Inc.'s PosiPenta score?
Profusa, Inc.'s PosiPenta is 60.24 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Profusa, Inc. stand on the Penta Grid?
On the Penta Grid this week, Profusa, Inc. is Grid #143 of 837 in the Healthcare sector in United States, and Grid #594 of 4,000 in United States.
Which PosiPenta pillar is strongest for Profusa, Inc.?
Earnings (growth), with a score of 100 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Profusa, Inc.?
Nitro (momentum), with a score of 1 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.